154 related articles for article (PubMed ID: 1743375)
21. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
Evans AT; Orrell JM; Grant A
J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
[TBL] [Abstract][Full Text] [Related]
22. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
23. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
24. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
Fogt F; Vortmeyer AO; Tahan SR
Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
26. Histologic mimics of malignant melanoma.
Bsirini C; Smoller BR
Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
[TBL] [Abstract][Full Text] [Related]
27. Fascin expression in melanocytic lesions of the skin.
YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
[TBL] [Abstract][Full Text] [Related]
28. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
[TBL] [Abstract][Full Text] [Related]
30. The role of R21 expression in differential diagnosis of melanocytic lesions.
Turcan D; Paşaoğlu Ö; Arik D
Indian J Pathol Microbiol; 2023; 66(4):804-809. PubMed ID: 38084536
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
32. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
[TBL] [Abstract][Full Text] [Related]
33. Nucleolar organizer regions in conjunctival nevi and melanomata.
Koren R; Rath-Wolfson L; Appel I; Pe'er J; Paz A; Klein T; Klein B; Mishaeli M; Gal R
Oncol Rep; 1998; 5(5):1079-81. PubMed ID: 9683812
[TBL] [Abstract][Full Text] [Related]
34. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
Howat AJ; Giri DD; Cotton DW; Slater DN
Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
[TBL] [Abstract][Full Text] [Related]
35. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
Pfau A; Eckert F; Schröpfer T; Rüschoff J
Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
[TBL] [Abstract][Full Text] [Related]
36. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma.
Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F
J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576
[TBL] [Abstract][Full Text] [Related]
37. Digital computer analysis of dermatoscopical images of 260 melanocytic skin lesions; perimeter/area ratio for the differentiation between malignant melanomas and melanocytic nevi.
Fikrle T; Pizinger K
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):48-55. PubMed ID: 17207167
[TBL] [Abstract][Full Text] [Related]
38. Nevi, other than dysplastic and Spitz nevi.
Cochran AJ; Bailly C; Paul E; Dolbeau D
Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar organizer regions in melanocytic dysplasia and melanoma.
Fallowfield ME; Dodson AR; Cook MG
Histopathology; 1988 Jul; 13(1):95-9. PubMed ID: 3209193
[TBL] [Abstract][Full Text] [Related]
40. Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions.
Steiner A; Binder M; Schemper M; Wolff K; Pehamberger H
J Am Acad Dermatol; 1993 Oct; 29(4):581-8. PubMed ID: 8408794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
